In addition, the level of FSP1 was found to be associated with tumor ferroptosis resistance, revealing that inhibitors of FSP1, earlier described as iFSP1, could be utilized to kill osteosarcoma cells, and the treatment could be further potentiated by the loss of GPX4 activity (14). This evidence concerns the gene GPX4 and neoplasm.